Clinical Trials Logo

Clinical Trial Summary

Various methods exist for performing pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF), including thermal ablation and pulse-field ablation (PFA). However, in cases requiring a second PVI for recurrent AF, radiofrequency ablation (RFA) is utilized in nearly 95% of instances post-acquiring a 3D high-density map from the left atrium (LA). Up to 85% of patients experiencing recurrent AF after the initial PVI exhibit pulmonary vein (PV) reconnections, often identified as the cause of AF. PFA has demonstrated its safety and efficiency compared to RFA as a swift technique for performing ablation. Yet, whether PFA or RFA stands out as superior or safer when applied for a second PVI remains unclear, as no randomized controlled trial has investigated this comparison. The proposed REPEAT-AF trial aims to randomize 154 AF patients experiencing recurrent AF after the initial PVI, assigning them in a 1:1 ratio to either RFA or PFA. Each patient will receive an implantable cardiac monitor to precisely detect any AF recurrences.


Clinical Trial Description

This study involves assessing suitable patients through (a) review of the patient's medical/surgical history, (b) assessment of concomitant medications, (c) documentation of AF recurrence ≥30 seconds, (d) transthoracic echocardiogram (≤6 months prior), and (e) an evaluation by the treating cardiac electrophysiologist to confirm eligibility for repeat PVI. Qualified screened patients are eligible for study enrolment. All participating patients are required to provide written (or equivalent) informed consent, indicated by a dated signature of the subject or legal representative. The consent process must comply with applicable national regulations and use language understandable by the patient. The study will be conducted at 6 clinical centres/investigational sites across the Netherlands. Patients will be randomized (1:1) into a PFA or point-by-point RF ablation arm. Randomization will occur prior to the ablation procedure. A implantable cardiac monitor will be implanted in all randomised patients one month before ablation to accurately monitor any AF/atrial flutter (AFL)/ atrial tachycardia (AT) recurrence. Treatment allocation will be processed through the Dutch 'National Heart Registry' (NHR) data platform. Patients randomized to both arms of the study will be evaluated for PV isolation at the start of the ablation procedure. If PV reconnection is identified in patients in the point-by-point RF arm, re-ablation will occur according to the study protocol. Patients in the PFA arm will have PV reconnection determined using the FARAWAVE catheter. Those with no PV reconnection (100% PV isolation/durable PVI) will be followed in an observational registry. The PFA ablation arm involves the use of the Farastar generator system, Farawave ablation catheter, and Faradrive steering catheter for the procedure. The RF point-by-point ablation arm (control) involves RF ablation following standard practice. Patients will be closely monitored during the study for any adverse effects or procedure-related complications. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06199180
Study type Interventional
Source University Medical Center Groningen
Contact Yuri Blaauw, Dr.
Phone +31503616161
Email y.blaauw01@umcg.nl
Status Not yet recruiting
Phase N/A
Start date July 2024
Completion date July 2028

See also
  Status Clinical Trial Phase
Recruiting NCT05266144 - Atrial Fibrillation Patients Treated With Catheter Ablation
Recruiting NCT06202209 - The Impact of Autonomic Function on Atrial Fibrillation Recurrence After Pulmonary Vein Ablation
Not yet recruiting NCT04780438 - Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation. Early Phase 1
Not yet recruiting NCT06098989 - A Prospective Study of REPeat Ablation In Patients With Recurrent PERSistent Atrial Fibrillation: Pulmonary Vein Isolation vs. Adjunct Posterior Wall Isolation (REPAIR PERS-AF Study) N/A
Recruiting NCT05781282 - Pulmonary Vein (PV) Imaging by Intracardiac Echography (ICE) After Ablation Phase 4
Terminated NCT04704050 - Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence Phase 4
Recruiting NCT04968678 - Exploring P-Wave Duration in Arrhythmia Recurrence in Patients Undergoing AF Ablation
Completed NCT04964440 - Redo AF Sub Study (of the Pure EP 2.0 Main Study)
Not yet recruiting NCT06204640 - SPironolactONe for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation Phase 3
Recruiting NCT06253000 - Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium N/A
Recruiting NCT03075930 - Atrial Fibrillation Ablation Registry
Recruiting NCT05528419 - Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation Phase 4
Not yet recruiting NCT06130358 - Investigating the Effects of a Museum Intervention on the Psychological and Cardiac Health of Older Adults N/A
Completed NCT05486364 - DIGITal mOnitoring afTer Af abLation N/A
Recruiting NCT05159180 - Development of a New Impedance Mapping System for Ablation of Atrial Arrhythmias in Patients
Active, not recruiting NCT06111443 - Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation Phase 2/Phase 3